Genetically engineered animals for use as organ donors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

10172459

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods to manipulate animals such as pigs, and the animals and tissues thereby derived, to reduce their immunogenicity following implantation into humans, are described. These methods are based on the discovery that certain carbohydrate structures on pig tissues, which require expression of the gene encoding the .alpha. 1.fwdarw.3 galactosyl transferase enzyme, are targets for natural preformed antibodies of humans and elicit further antibody production in humans, while other carbohydrate structures do not or do so in a reduced amount. In the preferred embodiment, animals are produced by homologous recombination of the gene encoding .alpha. 1.fwdarw.3 galactosyl transferase in embryonic stem cells or by microinjection into embryos of sequences eliminating or decreasing expression of .alpha. 1.fwdarw.3 galactosyl transferase. In alternative embodiments, animals are produced having reduced amounts of .fwdarw.1.fwdarw.3 galactosyl epitopes or epitopes which are masked by sialylation or fucosylation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INTEGRIS BAPTIST MEDICAL CENTER INC3300 NORTHWEST EXPRESSWAY OKLAHOMA CITY OK 73112

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cooper, David K C Oklahoma City, OK 8 138
Koren, Eugen Oklahoma City, OK 17 173

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation